Market revenue in 2023 | USD 7.5 million |
Market revenue in 2030 | USD 17.2 million |
Growth rate | 12.6% (CAGR from 2023 to 2030) |
Largest segment | Kits & reagents |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Kits & Reagents, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Merck KGaA, Charles River Laboratories International Inc, Asahi Kasei Corp, Sartorius AG, Eurofins Scientific SE, PromoCell GmbH, ATCC, InvivoGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mycoplasma testing market will help companies and investors design strategic landscapes.
Kits & reagents was the largest segment with a revenue share of 57.33% in 2023. Horizon Databook has segmented the Norway mycoplasma testing market based on instruments, kits & reagents, services covering the revenue growth of each sub-segment from 2018 to 2030.
Norway has an advanced biotechnology industry, a favorable investment climate, supportive policies, and incentives for biotechnology & biopharmaceutical companies. In addition, Norway’s well-developed infrastructure, including advanced laboratories, manufacturing facilities, and quality control systems, supports the life sciences industry. Furthermore, the presence of established scientific institutions and emerging innovators in the CGT space is expected to support market growth over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway mycoplasma testing market , including forecasts for subscribers. This country databook contains high-level insights into Norway mycoplasma testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account